Diurnal Group Plc

A global specialty pharmaceutical company focussed on chronic endocrine diseases including Adrenal Insufficiency and Congenital Adrenal Hyperplasia

Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using proprietary formulations and novel physiological treatment regimes of approved drugs.

Diurnal products address the major unmet needs of endocrine (hormone) treatments for patients and can be rapidly taken through clinical development to key clinical value points that will underpin commercialisation of these differentiated drug products.

Diurnal is dedicated to the development of novel pysiological hormone replacement therapeutics for rare or chronic diseases including adrenal insufficiency such as congenital adrenal hyperplasia.